Supernus Pharm (SUPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SUPN | RDY | TSHA | ||
| Company | Supernus Pharm | Dr. Reddy's Laboratories Ltd ADR | Taysha Gene Therapies Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 47.85 | 14.54 | 6.46 | ||
| High | 50.60 | 14.54 | 6.58 | ||
| Low | 47.54 | 13.85 | 6.26 | ||
| Latest | 50.44 | 14.12 | 6.49 | ||
| Change | +2.50 | -0.51 | -0.01 | ||
| % Change | +5.21% | -3.49% | -0.23% | ||
| Volume | 1,430,327 | 4,492,484 | 2,606,409 | ||
| 20-Day Average Volume | 926,096 | 2,772,804 | 4,067,605 | ||
| Previous Close | 47.94 | 14.63 | 6.50 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 45.81 | 14.04 | 6.27 | ||
| 20-Day Raw Stochastic | 98.04% | 40.15% | 65.95% | ||
| 20-Day Relative Strength | 62.36 | 52.32 | 54.69 | ||
| Weighted Alpha | +39.40 | -1.34 | +66.15 | ||
| Today's Opinion | 8% Buy | 40% Buy | 100% Buy | ||
| Previous Opinion | 48% Sell | 40% Buy | 100% Buy | ||
| Last Month's Opinion | 72% Sell | 100% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.45% since 06/30/26 | -2.55% since 06/30/26 | -4.77% since 06/30/26 | ||
| Low | 45.99 on 07/01/26 | 13.85 on 07/08/26 | 6.24 on 07/06/26 | ||
| High | 50.60 on 07/08/26 | 14.72 on 07/07/26 | 6.85 on 07/01/26 | ||
| 1-Month | |||||
| %Chg | +13.40% since 06/08/26 | +6.73% since 06/08/26 | +19.43% since 06/08/26 | ||
| Low | 42.45 on 06/16/26 | 13.08 on 06/17/26 | 5.26 on 06/09/26 | ||
| High | 50.60 on 07/08/26 | 15.67 on 06/26/26 | 7.12 on 06/30/26 | ||
| 3-Month | |||||
| %Chg | -2.27% since 04/08/26 | +6.65% since 04/08/26 | +42.53% since 04/08/26 | ||
| Low | 42.45 on 06/16/26 | 12.19 on 05/12/26 | 4.34 on 04/10/26 | ||
| High | 52.96 on 05/06/26 | 15.67 on 06/26/26 | 7.30 on 05/06/26 | ||
| 6-Month | |||||
| %Chg | -1.43% since 01/08/26 | +5.77% since 01/08/26 | +26.17% since 01/08/26 | ||
| Low | 42.45 on 06/16/26 | 12.19 on 05/12/26 | 4.03 on 03/30/26 | ||
| High | 59.68 on 02/25/26 | 15.67 on 06/26/26 | 7.30 on 05/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,782,438 | 12,211,179 | 1,867,846 | ||
| Shares Outstanding, K | 58,040 | 834,667 | 287,361 | ||
| Annual Sales | 718,950,000 | 3,580,000,000 | 9,770,000 | ||
| Annual Net Income | -38,550,000 | 456,000,000 | -109,000,000 | ||
| Last Quarter Sales | 207,710,000 | 593,010,000 | 5,490,000 | ||
| Last Quarter Net Income | -2,290,000 | -10,780,000 | -27,850,000 | ||
| 60-Month Beta | 0.54 | 0.25 | 1.17 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.59 on 05/05/26 | 0.06 on 05/12/26 | -0.12 on 05/06/26 | ||
| Earnings Date | 08/04/26 | 07/22/26 | 08/11/26 | ||
| Most Recent Dividend | N/A | 0.071 on 07/25/25 | N/A | ||
| Next Ex-Dividends Date | N/A | 07/24/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 19.36 | 23.54 | 0.00 | ||